Critical contribution of CD28-CD80/cd86 costimulatory pathway to protection from Trypanosoma cruzi infection

Yasushi Miyahira, Masaharu Katae, Seiki Kobayashi, Tsutomu Takeuchi, Yoshinosuke Fukuchi, Ryo Abe, Ko Okumura, Hideo Yagita, Takashi Aoki

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The CD28-CD80/CD86-mediated T-cell costimulatory pathway has been variably implicated in infectious immunity. In this study, we investigated the role of this costimulatory pathway in resistance to Trypanosoma cruzi infection by using CD28-deficient mice and blocking antibodies against CD80 and CD86. CD28-deficient mice exhibited markedly exacerbated T. cruzi infection, as evidenced by unrelenting parasitemia and 100% mortality after infection with doses that are nonlethal in wild-type mice. The blockade of both CD80 and CD86 by administering specific monoclonal antibodies also exacerbated T. cruzi infection in wild-type mice. Splenocytes from T. cruzi-infected, CD28-deficient mice exhibited greatly impaired gamma interferon production in response to T. cruzi antigen stimulation in vitro compared to those from infected wild-type mice. The induction of T. cruzi antigen-specific CD8+ T cells was also impaired in T. cruzi-infected, CD28-deficient mice. In addition to these defects in natural protection against T. cruzi infection, CD28-deficient mice were also defective in the induction of CD8+-T-cell-mediated protective immunity against T. cruzi infection by DNA vaccination. These results demonstrate, for the first time, a critical contribution of the CD28-CD80/CD86 costimulatory pathway not only to natural protection against primary T. cruzi infection but also to DNA vaccine-induced protective immunity to Chagas' disease.

Original languageEnglish
Pages (from-to)3131-3137
Number of pages7
JournalInfection and Immunity
Volume71
Issue number6
DOIs
Publication statusPublished - 2003 Jun 1

Fingerprint

Trypanosoma cruzi
Infection
Viral Tumor Antigens
T-Lymphocytes
Immunity
DNA Vaccines
Blocking Antibodies
Parasitemia
Chagas Disease
Cellular Immunity
Interferon-gamma
Vaccination
Monoclonal Antibodies
Mortality
DNA

ASJC Scopus subject areas

  • Immunology

Cite this

Miyahira, Y., Katae, M., Kobayashi, S., Takeuchi, T., Fukuchi, Y., Abe, R., ... Aoki, T. (2003). Critical contribution of CD28-CD80/cd86 costimulatory pathway to protection from Trypanosoma cruzi infection. Infection and Immunity, 71(6), 3131-3137. https://doi.org/10.1128/IAI.71.6.3131-3137.2003

Critical contribution of CD28-CD80/cd86 costimulatory pathway to protection from Trypanosoma cruzi infection. / Miyahira, Yasushi; Katae, Masaharu; Kobayashi, Seiki; Takeuchi, Tsutomu; Fukuchi, Yoshinosuke; Abe, Ryo; Okumura, Ko; Yagita, Hideo; Aoki, Takashi.

In: Infection and Immunity, Vol. 71, No. 6, 01.06.2003, p. 3131-3137.

Research output: Contribution to journalArticle

Miyahira, Y, Katae, M, Kobayashi, S, Takeuchi, T, Fukuchi, Y, Abe, R, Okumura, K, Yagita, H & Aoki, T 2003, 'Critical contribution of CD28-CD80/cd86 costimulatory pathway to protection from Trypanosoma cruzi infection', Infection and Immunity, vol. 71, no. 6, pp. 3131-3137. https://doi.org/10.1128/IAI.71.6.3131-3137.2003
Miyahira, Yasushi ; Katae, Masaharu ; Kobayashi, Seiki ; Takeuchi, Tsutomu ; Fukuchi, Yoshinosuke ; Abe, Ryo ; Okumura, Ko ; Yagita, Hideo ; Aoki, Takashi. / Critical contribution of CD28-CD80/cd86 costimulatory pathway to protection from Trypanosoma cruzi infection. In: Infection and Immunity. 2003 ; Vol. 71, No. 6. pp. 3131-3137.
@article{a5305f132d564603b6e0e5061d7ca2e7,
title = "Critical contribution of CD28-CD80/cd86 costimulatory pathway to protection from Trypanosoma cruzi infection",
abstract = "The CD28-CD80/CD86-mediated T-cell costimulatory pathway has been variably implicated in infectious immunity. In this study, we investigated the role of this costimulatory pathway in resistance to Trypanosoma cruzi infection by using CD28-deficient mice and blocking antibodies against CD80 and CD86. CD28-deficient mice exhibited markedly exacerbated T. cruzi infection, as evidenced by unrelenting parasitemia and 100{\%} mortality after infection with doses that are nonlethal in wild-type mice. The blockade of both CD80 and CD86 by administering specific monoclonal antibodies also exacerbated T. cruzi infection in wild-type mice. Splenocytes from T. cruzi-infected, CD28-deficient mice exhibited greatly impaired gamma interferon production in response to T. cruzi antigen stimulation in vitro compared to those from infected wild-type mice. The induction of T. cruzi antigen-specific CD8+ T cells was also impaired in T. cruzi-infected, CD28-deficient mice. In addition to these defects in natural protection against T. cruzi infection, CD28-deficient mice were also defective in the induction of CD8+-T-cell-mediated protective immunity against T. cruzi infection by DNA vaccination. These results demonstrate, for the first time, a critical contribution of the CD28-CD80/CD86 costimulatory pathway not only to natural protection against primary T. cruzi infection but also to DNA vaccine-induced protective immunity to Chagas' disease.",
author = "Yasushi Miyahira and Masaharu Katae and Seiki Kobayashi and Tsutomu Takeuchi and Yoshinosuke Fukuchi and Ryo Abe and Ko Okumura and Hideo Yagita and Takashi Aoki",
year = "2003",
month = "6",
day = "1",
doi = "10.1128/IAI.71.6.3131-3137.2003",
language = "English",
volume = "71",
pages = "3131--3137",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "6",

}

TY - JOUR

T1 - Critical contribution of CD28-CD80/cd86 costimulatory pathway to protection from Trypanosoma cruzi infection

AU - Miyahira, Yasushi

AU - Katae, Masaharu

AU - Kobayashi, Seiki

AU - Takeuchi, Tsutomu

AU - Fukuchi, Yoshinosuke

AU - Abe, Ryo

AU - Okumura, Ko

AU - Yagita, Hideo

AU - Aoki, Takashi

PY - 2003/6/1

Y1 - 2003/6/1

N2 - The CD28-CD80/CD86-mediated T-cell costimulatory pathway has been variably implicated in infectious immunity. In this study, we investigated the role of this costimulatory pathway in resistance to Trypanosoma cruzi infection by using CD28-deficient mice and blocking antibodies against CD80 and CD86. CD28-deficient mice exhibited markedly exacerbated T. cruzi infection, as evidenced by unrelenting parasitemia and 100% mortality after infection with doses that are nonlethal in wild-type mice. The blockade of both CD80 and CD86 by administering specific monoclonal antibodies also exacerbated T. cruzi infection in wild-type mice. Splenocytes from T. cruzi-infected, CD28-deficient mice exhibited greatly impaired gamma interferon production in response to T. cruzi antigen stimulation in vitro compared to those from infected wild-type mice. The induction of T. cruzi antigen-specific CD8+ T cells was also impaired in T. cruzi-infected, CD28-deficient mice. In addition to these defects in natural protection against T. cruzi infection, CD28-deficient mice were also defective in the induction of CD8+-T-cell-mediated protective immunity against T. cruzi infection by DNA vaccination. These results demonstrate, for the first time, a critical contribution of the CD28-CD80/CD86 costimulatory pathway not only to natural protection against primary T. cruzi infection but also to DNA vaccine-induced protective immunity to Chagas' disease.

AB - The CD28-CD80/CD86-mediated T-cell costimulatory pathway has been variably implicated in infectious immunity. In this study, we investigated the role of this costimulatory pathway in resistance to Trypanosoma cruzi infection by using CD28-deficient mice and blocking antibodies against CD80 and CD86. CD28-deficient mice exhibited markedly exacerbated T. cruzi infection, as evidenced by unrelenting parasitemia and 100% mortality after infection with doses that are nonlethal in wild-type mice. The blockade of both CD80 and CD86 by administering specific monoclonal antibodies also exacerbated T. cruzi infection in wild-type mice. Splenocytes from T. cruzi-infected, CD28-deficient mice exhibited greatly impaired gamma interferon production in response to T. cruzi antigen stimulation in vitro compared to those from infected wild-type mice. The induction of T. cruzi antigen-specific CD8+ T cells was also impaired in T. cruzi-infected, CD28-deficient mice. In addition to these defects in natural protection against T. cruzi infection, CD28-deficient mice were also defective in the induction of CD8+-T-cell-mediated protective immunity against T. cruzi infection by DNA vaccination. These results demonstrate, for the first time, a critical contribution of the CD28-CD80/CD86 costimulatory pathway not only to natural protection against primary T. cruzi infection but also to DNA vaccine-induced protective immunity to Chagas' disease.

UR - http://www.scopus.com/inward/record.url?scp=0038444114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038444114&partnerID=8YFLogxK

U2 - 10.1128/IAI.71.6.3131-3137.2003

DO - 10.1128/IAI.71.6.3131-3137.2003

M3 - Article

C2 - 12761091

AN - SCOPUS:0038444114

VL - 71

SP - 3131

EP - 3137

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 6

ER -